Scaling‐up: Building, Leading and Sustaining Rapid Growth Over Time
Journal of Management Studies · 2023-05 · 60 (3) · 581-604
DOI: 10.1111/joms.12910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Management Studies, online erschienen am 07.02.2023. Verfasst von Justin J. P. Jansen und 4 weiteren Autor:innen. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Even as research on scaling and high growth firms (HFGs) is gaining momentum, the corpus of accumulated research remains largely fragmented and dispersed, with little in the way of a central conceptual foundation or ‘theoretical true north’ to guide empirical development. This Special Issue provides a forum for works that push the theoretical and empirical frontiers of research on scaling and HGFs. We provide a multi‐dimensional conceptualization that recognizes scaling as a dynamic capability entailing routines and processes for expansion, replication, and synchronization. We also present a typology that specifies the multiple types of HGFs. Inspired by the four studies published in the special issue, we finally outline five priorities for future research.
Zitieren
APA
Jansen, J. J. P., Heavey, C., Mom, T. J. M., Simsek, Z., & Zahra, S. A. (2023). Scaling‐up: Building, Leading and Sustaining Rapid Growth Over Time. Journal of Management Studies, 60(3), 581-604. https://doi.org/10.1111/joms.12910
Vancouver
Jansen JJP, Heavey C, Mom TJM, Simsek Z, Zahra SA. Scaling‐up: Building, Leading and Sustaining Rapid Growth Over Time. Journal of Management Studies. 2023;60(3):581-604. doi:10.1111/joms.12910
BibTeX
@article{Jansen2023,
author = {Jansen, Justin J. P. and Heavey, Ciaran and Mom, Tom J. M. and Simsek, Zeki and Zahra, Shaker A.},
title = {Scaling‐up: Building, Leading and Sustaining Rapid Growth Over Time},
journal = {Journal of Management Studies},
year = {2023},
volume = {60},
number = {3},
pages = {581--604},
doi = {10.1111/joms.12910}
}
EUVIMED